Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OSBP | P22059 | 4/20 | 0.66 |
| ▸ | RORC | P51449 | 3/20 | 0.66 |
| ▸ | USP2 | O75604 | 2/20 | 0.66 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.66 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.66 |
| ▸ | POLA1 | P09884 | 1/20 | 0.64 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.57 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.57 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.56 |
| ▸ | GRIN2A | Q12879 | 3/20 | 0.56 |
| ▸ | FNTA | P49354 | 1/20 | 0.55 |
| ▸ | FNTB | P49356 | 1/20 | 0.55 |
| ▸ | CRYAB | P02511 | 1/20 | 0.54 |
| ▸ | HMGCR | P04035 | 1/20 | 0.54 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.54 |
| ▸ | ITGAV | P06756 | 1/20 | 0.54 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.54 |
| ▸ | NPC1L1 | Q9UHC9 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7043800 | 1.00 | OSBP (0.66) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL11656047 | 0.94 | OSBP (0.66) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL11656049 | 0.92 | OSBP (0.66) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL9446912 | 0.90 | POLA1 (0.64) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL6903726 | 0.89 | OSBP (0.62) | OSBPRORCUSP2CYP46A1OSBP2 | |
| Cholesterol SCHEMBL1296896 | 0.89 | OSBP (0.82) | OSBPRORCUSP2CYP46A1OSBP2 | |
| Cholesterol SCHEMBL29033213 | 0.89 | OSBP (0.82) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL4432535 | 0.88 | OSBP (0.60) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL6904293 | 0.88 | OSBP (0.62) | OSBPRORCUSP2CYP46A1OSBP2 | |
| SCHEMBL10334278 | 0.87 | OSBP (0.59) | OSBPRORCUSP2CYP46A1OSBP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12465592-B2 | Structured encapsulated silicon-containing particles | SISAF LIMITED (GB) | 2025-11-11 | — | — | US | claimed |
| EP-3946279-B1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LTD (GB) | 2025-07-23 | — | — | EP | claimed |
| US-20220184038-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LIMITED (GB) | 2022-06-16 | — | — | US | claimed |
| EP-3946279-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | Sisaf Ltd (GB) | 2022-02-09 | — | — | EP | claimed |
| WO-2020193998-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LIMITED (GB) | 2020-10-01 | — | — | WO | claimed |
| EP-3714879-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | Sisaf Ltd (GB) | 2020-09-30 | — | — | EP | claimed |
| EP-2507310-B1 | MODIFIED RUBBER COMPOSITIONS AND METHODS OF PREPARATION | BRIDGESTONE CORP (JP) | 2017-09-06 | — | — | EP | claimed |
| EP-0988031-B1 | PHARMACEUTICAL COMPOSITION IN FORM OF SOLID LIPIDIC MICROPARTICLES SUITABLE TO PARENTERAL ADMINISTRATION | GASCO MARIA ROSA (IT) | 2003-04-02 | — | — | EP | claimed |
| US-6238694-B1 | Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration | GASCO MARIA ROSA (IT) | 2001-05-29 | — | — | US | claimed |
| EP-0988031-A1 | PHARMACEUTICAL COMPOSITION IN FORM OF SOLID LIPIDIC MICROPARTICLES SUITABLE TO PARENTERAL ADMINISTRATION | Gasco, Maria Rosa (IT) | 2000-03-29 | — | — | EP | claimed |
| WO-1998056362-A1 | PHARMACEUTICAL COMPOSITION IN FORM OF SOLID LIPIDIC MICROPARTICLES SUITABLE TO PARENTERAL ADMINISTRATION | GASCO MARIA ROSA (IT) | 1998-12-17 | — | — | WO | claimed |
| EP-0404639-B1 | Cholesteric liquid composition and color-forming liquid crystal composite products | SHINKO ELECTRIC WORKS CO LTD (JP) | 1995-08-30 | — | — | EP | claimed |
| EP-0400220-B1 | Laminated article for identification purposes | AGFA GEVAERT NV (BE) | 1994-08-31 | — | — | EP | claimed |
| US-12465592-B2 | Structured encapsulated silicon-containing particles | SISAF LIMITED (GB) | 2025-11-11 | — | — | US | disclosed |
| EP-3946279-B1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SISAF LTD (GB) | 2025-07-23 | — | — | EP | disclosed |
| US-12001091-B2 | Spatially variable liquid crystal diffraction gratings | MAGIC LEAP, INC. (US) | 2024-06-04 | — | — | US | disclosed |
| US-5510913-A | Head-up display system where polarized light from a display impinges on a glass plate containing twisted nematic liquid crystal at the plate's Brewsters angle | CENTRAL GLASS COMPANY, LIMITED (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0580143-A2 | Head-up display system | CENTRAL GLASS COMPANY, LIMITED (JP) | 1994-01-26 | — | — | EP | disclosed |
| US-4420224-A | Liquid crystal display cell, process for its production and cell plate | BBC BROWN, BOVERI & COMPANY LIMITED (CH) | 1983-12-13 | — | — | US | disclosed |
| EP-0025037-B1 | LIQUID CRYSTAL DISPLAY CELL AND PROCESS FOR MANUFACTURING THEREOF | BBC Aktiengesellschaft Brown, Boveri & Cie. (CH) | 1983-01-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12465592-B2 | Structured encapsulated silicon-containing particles | SGMS1, SGMS2, SMURF1 | OSBP 182/4885RORC 1295/4885USP2 1367/4885 |
| US-20220184038-A1 | STRUCTURED ENCAPSULATED SILICON-CONTAINING PARTICLES | SGMS1, SGMS2, SMURF1 | OSBP 182/4885RORC 1295/4885USP2 1367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.